Takeda’s Febuxostat Finally Gets Advisory Panel Review
The subject of FDA “approvable” letters in 2005 and 2006, the investigational gout drug won EU approval in May.
The subject of FDA “approvable” letters in 2005 and 2006, the investigational gout drug won EU approval in May.